News & Events

Read about our latest product developments and partnerships, industry advances and events.

Dr. Samuel Henderson, Accera's V.P. of Research and Development, to Present at the 249th American Chemical Society National Meeting

February 20, 2015

Presentation is entitled: Induced ketosis in mild to moderate Alzheimer's disease

BROOMFIELD, CO., Feb 10, 2015 (PRNEWSWIRE) – Accera, Inc, a leader in the development of new therapies to treat neurological disorders, today announced that Dr. Samuel Henderson, Accera's Vice President of Research and Development, will present a review of the company's technology at the 249th American Chemical Society National Meeting that will be held in Denver, Colorado, March 22-26, 2015.

The presentation entitled, "Induced ketosis in mild to moderate Alzheimer's disease" will take place in the Colorado Biotechnology Session at 10:10-10:50am on Sunday, March 22nd in the Mt. Sopris Room at the Grand Hyatt Denver.

BacktoTop